Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Firebrick Pharma Limited ( (AU:FRE) ) has provided an update.
Firebrick Pharma Limited has notified the ASX of the cessation of 180,000 options, which expired unexercised on April 1, 2026. The expiry of these options marginally reduces the company’s potential diluted share count and reflects routine management of its capital structure, with limited immediate impact on existing shareholders.
The announcement provides updated information on Firebrick Pharma’s issued capital, confirming that no conversion or exercise took place before the options’ expiry. This routine securities update helps maintain transparency for investors and ensures the market has accurate data on the company’s outstanding equity instruments.
More about Firebrick Pharma Limited
Firebrick Pharma Limited, listed on the ASX under the code FRE, operates in the pharmaceutical sector. The company issues various forms of securities, including options and other convertible instruments, as part of its capital management and financing activities in the market.
Average Trading Volume: 89,392
Technical Sentiment Signal: Sell
Current Market Cap: A$14.39M
See more insights into FRE stock on TipRanks’ Stock Analysis page.